After exposure to irradiation or to other agents that induce DNA damage, mammalian cells delay in cell cycle progression through G2. There is suggestive evidence that the delay at the G2 checkpoint may effect the outcome of cellular survival in response to DNA damage. Since many of the drugs used for cancer chemotherapy, as well as radiation, damage DNA and lead to a G2 delay, understanding the G2 delay may have significant implications for cancer chemotherapy. In this proposal we will explore the mechanisms leading to the G2 delay and evaluate whether the length of the G2 delay affects survival in tumor cells. We have found that the levels of cyclin B1 are greatly reduced in many cell types after exposure to DNA damaging agents. Since cyclin B1 is required for the transition through G2 into mitosis, it seemed plausible that the decrease in cyclin B1 levels induced by radiation might contribute to the G2 delay. We have confirmed this hypothesis by experimentally manipulating the expression of cyclin B1. Decreased expression of cyclin B1 leads to a prolonged G2 delay. Conversely, increased B1 expression after irradiation greatly shortened the G2 delay after irradiation, but did not eliminate it. Enhanced expression of cyclin B1 had no effect on the cell cycle of un-irradiated cells. These data demonstrated that the levels of cyclin B1 regulate the G2 delay after irradiation and suggest that cyclin B1 independent mechanisms may also exist. In this application we propose to extend these observations along three main avenues. First to determine if the levels of cyclin B1 control of G2 delay after other forms of DNA damage in a variety of cellular systems and to determine whether the same multi-factorial mechanisms are also at work; second to determine whether phosphorylation of p34/cdc2 influences the G2 delay and third to determine whether manipulation of the G2 delay can affect sensitivity to chemotherapeutic agents or to radiation can be influence by manipulation of the G2 checkpoint.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
3P01CA075138-03S1
Application #
6323305
Study Section
Project Start
2000-06-01
Project End
2001-05-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
3
Fiscal Year
2000
Total Cost
$140,673
Indirect Cost
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Qayum, Naseer; Im, Jaehong; Stratford, Michael R et al. (2012) Modulation of the tumor microvasculature by phosphoinositide-3 kinase inhibition increases doxorubicin delivery in vivo. Clin Cancer Res 18:161-9
Higgins, Geoff S; Prevo, Remko; Lee, Yin-Fai et al. (2010) A small interfering RNA screen of genes involved in DNA repair identifies tumor-specific radiosensitization by POLQ knockdown. Cancer Res 70:2984-93
Dorsey, Jay F; Mintz, Akiva; Tian, Xiaobing et al. (2009) Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and paclitaxel have cooperative in vivo effects against glioblastoma multiforme cells. Mol Cancer Ther 8:3285-95
Hamilton, Julie; Grawenda, Anna M; Bernhard, Eric J (2009) Phosphatase inhibition and cell survival after DNA damage induced by radiation. Cancer Biol Ther 8:1577-86
Hamilton, Julie; Higgins, Geoff; Bernhard, Eric J (2009) Conventional radiotherapy or hypofractionation? A study of molecular changes resulting from different radiation fractionation schemes. Cancer Biol Ther 8:774-6
Qayum, Naseer; Muschel, Ruth J; Im, Jae Hong et al. (2009) Tumor vascular changes mediated by inhibition of oncogenic signaling. Cancer Res 69:6347-54
Al-Assar, Osama; Muschel, Ruth J; Mantoni, Tine S et al. (2009) Radiation response of cancer stem-like cells from established human cell lines after sorting for surface markers. Int J Radiat Oncol Biol Phys 75:1216-25
Mantoni, Tine S; Schendel, Roy R E; Rodel, Franz et al. (2008) Stromal SPARC expression and patient survival after chemoradiation for non-resectable pancreatic adenocarcinoma. Cancer Biol Ther 7:1806-15
Plastaras, John P; Dorsey, Jay F; Carroll, Kristina et al. (2008) Role of PI3K/Akt signaling in TRAIL- and radiation-induced gastrointestinal apoptosis. Cancer Biol Ther 7:2047-53
Finnberg, Niklas; Wambi, Chris; Ware, Jeffrey H et al. (2008) Gamma-radiation (GR) triggers a unique gene expression profile associated with cell death compared to proton radiation (PR) in mice in vivo. Cancer Biol Ther 7:2023-33

Showing the most recent 10 out of 98 publications